1.086SEK-1.63%Mkt Cap: 35.40M $P/E: —Today
Intervacc AB (publ) develops novel veterinary vaccines for animals in Sweden. The company's product pipeline includes Strangvac, a vaccine against equine strangles for horses; INV274, antigens for a vaccine against strep…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap35.40M $
Enterprise Value23.32M $
Revenue (TTM)1.76M $
Gross Profit-1.10M $
Net Income (TTM)-7.73M $
Revenue/Share0.0052 USD
Last Price1.086 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.33
PEG—
EV/EBITDA-3.23
EV/Revenue13.23
P/S20.12
P/B1.46
EPS (TTM)-0.25
EPS (Forward)-0.82
52W Range
0.572058% of range1.462
52W High1.462 SEK
52W Low0.5720 SEK
Profitability
Gross Margin-57.18%
Oper. Margin-304.74%
EBITDA Margin0.00%
Profit Margin-402.32%
ROE-29.40%
ROA-27.45%
Growth
Revenue Growth-3.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.29M $
CapEx (TTM)108.28K $
FCF Margin-229.82%
FCF Yield-11.45%
Net Debt-12.13M $
Net Debt/EBITDA1.68
Balance Sheet
Debt/Equity0.00
Current Ratio4.51
Quick Ratio4.15
Book Value/Sh0.7430 SEK
Cash/Share0.3800 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.050 SEK
Upside (mean)+88.8%
Target Range2.000 SEK – 2.100 SEK
SEK2.000+88.8% to meanSEK2.100
# Analysts2
Ownership
Shares Out.340.81M
Float192.35M
Insiders19.34%
Institutions34.37%
Technical
SMA 501.260 (-13.8%)
SMA 2001.024 (+6.1%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)300.24K
Avg Vol (10d)265.74K
Technical Indicators
RSI (14)33.3
MACD-0.0299
MACD Signal-0.0172
MACD Hist.-0.0127
BB Upper1.326 SEK
BB Middle1.215 SEK
BB Lower1.104 SEK
BB Width18.28%
ATR (14)0.0680 SEK
Vol Ratio (20d)6.13x